What does ISO 10993-11 systemic toxicity testing mean in practice?
ISO 10993‑11 evaluates systemic toxicological effects and is a key component of the ISO 10993‑1 Biological Evaluation. While BET/LAL and MAT focus on endotoxin and pyrogenicity, ISO 10993‑11 addresses broader toxicological endpoints, including acute, subacute and subchronic systemic reactions triggered by compounds released from the device. This standard is particularly relevant for implantable, invasive and long‑term use devices where systemic exposure is plausible.
HygCen Germany performs BET/LAL (endotoxin) and MAT (pyrogenicity) tests in-house and, if required, coordinates systemic toxicity testing according to ISO 10993-11 through qualified partner laboratories. Sample preparation is carried out in accordance with relevant microbiological standards, in particular ISO 11737-3. This results in a consistent testing basis that integrates both biological and analytical risks.
Systemic toxicity testing may address acute toxicity, organ‑specific effects, metabolic disturbances or reactions triggered by low‑molecular constituents. Results are interpreted alongside chemical data (ISO 10993‑18) and other biological endpoints such as cytotoxicity, genotoxicity and hemocompatibility. Only this combined evaluation enables a regulator‑ready toxicological risk assessment.
The final assessment is documented in the Biological Evaluation Plan (BEP) and Biological Evaluation Report (BER), typically prepared by independent toxicologists. Complete documentation—including sample logic, extraction parameters, data interpretation and QES‑signed reporting—is essential to meet MDR expectations and support regulatory submissions.
Norm criteria – at a glance
| Norm criterion | Requirement / content | Note |
|---|---|---|
| Endotoxin | BET / LAL (in-house) | Limits depend on use |
| Pyrogenicity | MAT (in-house) | Broader than endotoxin |
| Sample preparation | ISO 10993-12 aligned | Risk-based |
| ISO 10993-11 | Partner coordination | HygCen project management |
| Integration | Input ISO 10993-1 | Assessed externally |
How we test your medical device – step by step
- Request a quote by phone or online. Key inputs: device, materials/components, contact type and exposure duration, and the device condition (e.g., sterilized/reprocessed).
- Send your device after accepting the quote. Please provide the sample in the marketed/used state where possible (including reprocessed state if applicable).
- Upon receipt, we start testing and document sample logistics and—where relevant—ISO 10993-12 aligned preparation/extraction parameters.
- We perform in-house BET/LAL (endotoxin) and MAT (pyrogenicity). If ISO 10993-11 systemic toxicity becomes necessary, we coordinate testing via qualified partners while HygCen Germany remains your single point of contact.
- You receive a digital, QES-signed report with professional interpretation. Upon request, we coordinate next steps through external toxicology (ISO 10993-17) and the ISO 10993-1 Biological Evaluation.
Why HygCen?
- DAkkS accredited testing laboratory (DIN EN ISO/IEC 17025) with GLP-compliant processes.
- Risk-based study design aligned with intended contact type, duration and use.
- Testing in the original state, including relevant processing/sterilization/reprocessing influences.
- Digital, QES-signed report with expert interpretation for MDR technical documentation.
- One-stop coordination: in-house BET/LAL & MAT; if ISO 10993-11 systemic toxicity is required, we coordinate qualified partner testing while staying your single point of contact.
BET/LAL and MAT are necessary when a device may introduce pyrogenic or endotoxin contamination into blood, cerebrospinal fluid or other sensitive compartments. BET/LAL targets bacterial endotoxins, while MAT detects a broader range of pyrogens by measuring cytokine responses of human monocytes. The choice depends on device category, risk analysis and regulatory expectations.
Endotoxins are a subgroup of pyrogenic compounds originating from gram‑negative bacteria. Pyrogenicity, however, includes all fever‑inducing mechanisms, including those caused by non‑endotoxin substances. BET/LAL is specific to bacterial endotoxins, whereas MAT captures both endotoxin and non‑endotoxin pyrogens. Both tests are often used together to achieve comprehensive risk characterization.
BET/LAL and MAT are performed in‑house. Systemic toxicity testing under ISO 10993‑11 is coordinated via qualified external partners. HygCen Germany manages all logistics, sample strategy and reporting, ensuring consistent documentation that supports ISO 10993‑1 Biological Evaluation.
Sample preparation aligns with ISO 10993‑12 using risk‑based selection of extraction media, surface‑area‑to‑volume ratio and time–temperature profiles. Endotoxin‑controlled handling prevents artefacts. All details are documented in the report for regulatory traceability.
Additional systemic tests are required when chemical data (ISO 10993‑18), BET/LAL, MAT or other biological endpoints indicate potential systemic hazards. Long‑term implantable or high‑exposure devices often need multi‑tiered toxicological assessment. Decisions are made case‑by‑case within the BEP.